Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 4/2008

Open Access 01-08-2008 | Research article

Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane

Authors: René Huber, Christian Hummert, Ulrike Gausmann, Dirk Pohlers, Dirk Koczan, Reinhard Guthke, Raimund W Kinne

Published in: Arthritis Research & Therapy | Issue 4/2008

Login to get access

Abstract

Introduction

Rheumatoid arthritis (RA) is a chronic inflammatory and destructive joint disease characterized by overexpression of pro-inflammatory/pro-destructive genes and other activating genes (for example, proto-oncogenes) in the synovial membrane (SM). The gene expression in disease is often characterized by significant inter-individual variances via specific synchronization/desynchronization of gene expression. To elucidate the contribution of the variance to the pathogenesis of disease, expression variances were tested in SM samples of RA patients, osteoarthritis (OA) patients, and normal controls (NCs).

Method

Analysis of gene expression in RA, OA, and NC samples was carried out using Affymetrix U133A/B oligonucleotide arrays, and the results were validated by real-time reverse transcription-polymerase chain reaction. For the comparison between RA and NC, 568 genes with significantly different variances in the two groups (P ≤ 0.05; Bonferroni/Holm corrected Brown-Forsythe version of the Levene test) were selected. For the comparison between RA and OA, 333 genes were selected. By means of the Kyoto Encyclopedia of Genes and Genomes, the pathways/complexes significantly affected by higher gene expression variances were identified in each group.

Results

Ten pathways/complexes significantly affected by higher gene expression variances were identified in RA compared with NC, including cytokine–cytokine receptor interactions, the transforming growth factor-beta pathway, and anti-apoptosis. Compared with OA, three pathways with significantly higher variances were identified in RA (for example, B-cell receptor signaling and vascular endothelial growth factor signaling). Functionally, the majority of the identified pathways are involved in the regulation of inflammation, proliferation, cell survival, and angiogenesis.

Conclusion

In RA, a number of disease-relevant or even disease-specific pathways/complexes are characterized by broad intra-group inter-individual expression variances. Thus, RA pathogenesis in different individuals may depend to a lesser extent on common alterations of the expression of specific key genes, and rather on individual-specific alterations of different genes resulting in common disturbances of key pathways.
Appendix
Available only for authorised users
Literature
1.
Grassi W, De Angelis R, Lamanna G, Cervini C: The clinical features of rheumatoid arthritis. Eur J Radiol. 1998, 27 (Suppl 1): S18-S24. 10.1016/S0720-048X(98)00038-2.CrossRefPubMed
2.
Kinne RW, Palombo-Kinne E, Emmrich F: Activation of synovial fibroblasts in rheumatoid arthritis. Ann Rheum Dis. 1995, 54: 501-504. 10.1136/ard.54.6.501-b.PubMedCentralCrossRefPubMed
3.
Abeles AM, Pillinger MH: The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull NYU Hosp Jt Dis. 2006, 64: 20-24.PubMed
4.
Karouzakis E, Neidhart M, Gay RE, Gay S: Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett. 2006, 106: 8-13. 10.1016/j.imlet.2006.04.011.CrossRefPubMed
5.
6.
7.
Firestein GS: Evolving concepts of rheumatoid arthritis. Nature. 2003, 423: 356-361. 10.1038/nature01661.CrossRefPubMed
8.
Firestein GS: Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol. 2005, 11: S39-S44. 10.1097/01.rhu.0000166673.34461.33.CrossRefPubMed
9.
Postlethwaite AE, Holness MA, Katai H, Raghow R: Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992, 90: 1479-1485. 10.1172/JCI116015.PubMedCentralCrossRefPubMed
10.
Firestein GS, Manning AM: Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 1999, 42: 609-621. 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I.CrossRefPubMed
11.
Han Z, Boyle DL, Manning AM, Firestein GS: AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity. 1998, 28: 197-208. 10.3109/08916939808995367.CrossRefPubMed
12.
Pouw Kraan van der TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL: Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 2003, 48: 2132-2145. 10.1002/art.11096.CrossRefPubMed
13.
Beer S, Oleszewski M, Gutwein P, Geiger C, Altevogt P: Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule. J Cell Sci. 1999, 112 (Pt 16): 2667-2675.PubMed
14.
McCachren SS: Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 1991, 34: 1085-1093. 10.1002/art.1780340904.CrossRefPubMed
15.
Wu JJ, Lark MW, Chun LE, Eyre DR: Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem. 1991, 266: 5625-5628.PubMed
16.
Hardiman G: Microarrays Technologies 2006: an overview. Pharmacogenomics. 2006, 7: 1153-1158. 10.2217/14622416.7.8.1153.CrossRefPubMed
17.
Sultan M, Piccini I, Balzereit D, Herwig R, Saran NG, Lehrach H, Reeves RH, Yaspo ML: Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biol. 2007, 8: R91-10.1186/gb-2007-8-5-r91.PubMedCentralCrossRefPubMed
18.
Shervington A, Patel R, Lu C, Cruickshanks N, Lea R, Roberts G, Dawson T, Shervington L: Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma. Brain Res. 2007, 1134: 45-52. 10.1016/j.brainres.2006.11.093.CrossRefPubMed
19.
MacGlashan DW: Relationship between spleen tyrosine kinase and phosphatidylinositol 5' phosphatase expression and secretion from human basophils in the general population. J Allergy Clin Immunol. 2007, 119: 626-633. 10.1016/j.jaci.2006.09.040.CrossRefPubMed
20.
Chowers I, Liu D, Farkas RH, Gunatilaka TL, Hackam AS, Bernstein SL, Campochiaro PA, Parmigiani G, Zack DJ: Gene expression variation in the adult human retina. Hum Mol Genet. 2003, 12: 2881-2893. 10.1093/hmg/ddg326.CrossRefPubMed
21.
Storey JD, Madeoy J, Strout JL, Wurfel M, Ronald J, Akey JM: Gene-expression variation within and among human populations. Am J Hum Genet. 2007, 80: 502-509. 10.1086/512017.PubMedCentralCrossRefPubMed
22.
Levene H: Robust tests for equality of variances. Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling. Edited by: Olkin I, Ghurye SG, Hoeffding W, Madow WG, Mann HB. 1960, Palo Alto, CA: Stanford University Press, 278-292.
23.
Brown MB, Forsythe AB: Robust tests for equality of variances. J Amer Statist Assoc. 1974, 69: 364-367. 10.2307/2285659.CrossRef
24.
Holm S: A simple sequentially rejective multiple test procedure. Scand J Statist. 1979, 6: 65-70.
25.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed
26.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S, Mankin H, McShane DJ, Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986, 29: 1039-1049. 10.1002/art.1780290816.CrossRefPubMed
27.
Huber R, Kunisch E, Gluck B, Egerer R, Sickinger S, Kinne RW: Comparison of conventional and real-time RT-PCR for the quantitation of jun protooncogene mRNA and analysis of junB mRNA expression in synovial membranes and isolated synovial fibroblasts from rheumatoid arthritis patients. Z Rheumatol. 2003, 62: 378-389. 10.1007/s00393-003-0472-4.CrossRefPubMed
28.
Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003, 19: 185-193. 10.1093/bioinformatics/19.2.185.CrossRefPubMed
29.
30.
Fisher RA: The correlation between relatives on the supposition of mendelian inheritance. Trans Roy Soc Edinb. 1918, 52: 399-433.CrossRef
31.
Abdi H: Bonferroni and Sidak corrections for multiple comparisons. Encyclopedia of Measurement and Statistics. Edited by: Salkind NJ. 2007, Thousand Oaks, CA: SAGE Publications
32.
Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M: KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999, 27: 29-34. 10.1093/nar/27.1.29.PubMedCentralCrossRefPubMed
33.
34.
Edwards BJ, Haynes C, Levenstien MA, Finch SJ, Gordon D: Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies. BMC Genet. 2005, 6: 18-10.1186/1471-2156-6-18.PubMedCentralCrossRefPubMed
35.
Haupl T, Yahyawi M, Lubke C, Ringe J, Rohrlach T, Burmester GR, Sittinger M, Kaps C: Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007, 12: 328-340. 10.1177/1087057107299261.CrossRefPubMed
36.
Ospelt C, Gay S: Antirheumatic drugs and gene signatures. Curr Opin Investig Drugs. 2007, 8: 385-389.PubMed
37.
Paoloni-Giacobino A, Grimble R, Pichard C: Genetics and nutrition. Clin Nutr. 2003, 22: 429-435. 10.1016/S0261-5614(03)00064-5.CrossRefPubMed
38.
Hahn G, Stuhlmuller B, Hain N, Kalden JR, Pfizenmaier K, Burmester GR: Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest. 1993, 91: 862-870. 10.1172/JCI116307.PubMedCentralCrossRefPubMed
39.
Batliwalla FM, Baechler EC, Xiao X, Li W, Balasubramanian S, Khalili H, Damle A, Ortmann WA, Perrone A, Kantor AB, Gulko PS, Kern M, Furie R, Behrens TW, Gregersen PK: Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun. 2005, 6: 388-397. 10.1038/sj.gene.6364209.CrossRefPubMed
40.
Sweeney SE, Firestein GS: Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol. 2004, 36: 372-378. 10.1016/S1357-2725(03)00259-0.CrossRefPubMed
41.
Hammaker DR, Boyle DL, Chabaud-Riou M, Firestein GS: Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. J Immunol. 2004, 172: 1612-1618.CrossRefPubMed
42.
Liagre B, Vergne-Salle P, Leger DY, Beneytout JL: Inhibition of human rheumatoid arthritis synovial cell survival by hecogenin and tigogenin is associated with increased apoptosis, p38 mitogen-activated protein kinase activity and upregulation of cyclooxygenase-2. Int J Mol Med. 2007, 20: 451-460.PubMed
43.
Taranto E, Leech M: Expression and function of cell cycle proteins in rheumatoid arthritis synovial tissue. Histol Histopathol. 2006, 21: 205-211.PubMed
44.
Kurzik-Dumke U, Schick C, Rzepka R, Melchers I: Overexpression of human homologs of the bacterial DnaJ chaperone in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42: 210-220. 10.1002/1529-0131(199902)42:2<210::AID-ANR2>3.0.CO;2-U.CrossRefPubMed
45.
Kim SY, Han SW, Kim GW, Lee JM, Kang YM: TGF-beta1 polymorphism determines the progression of joint damage in rheumatoid arthritis. Scand J Rheumatol. 2004, 33: 389-394. 10.1080/03009740410010344.CrossRefPubMed
46.
Han SW, Kim GW, Seo JS, Kim SJ, Sa KH, Park JY, Lee J, Kim SY, Goronzy JJ, Weyand CM, Kang YM: VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford). 2004, 43: 1173-1177. 10.1093/rheumatology/keh281.CrossRef
47.
Martinez A, Valdivia A, Pascual-Salcedo D, Balsa A, Fernandez-Gutierrez B, De la CE, Urcelay E: Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis. J Rheumatol. 2006, 33: 842-846.PubMed
48.
Kinne RW, Liehr T, Beensen V, Kunisch E, Zimmermann T, Holland H, Pfeiffer R, Stahl HD, Lungershausen W, Hein G, Roth A, Emmrich F, Claussen U, Froster UG: Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases. Arthritis Res. 2001, 3: 319-330. 10.1186/ar322.PubMedCentralCrossRefPubMed
49.
Kinne RW, Kunisch E, Beensen V, Zimmermann T, Emmrich F, Petrow P, Lungershausen W, Hein G, Braun RK, Foerster M, Kroegel C, Winter R, Liesaus E, Fuhrmann RA, Roth A, Claussen U, Liehr T: Synovial fibroblasts and synovial macrophages from patients with rheumatoid arthritis and other inflammatory joint diseases show chromosomal aberrations. Genes Chromosomes Cancer. 2003, 38: 53-67. 10.1002/gcc.10242.CrossRefPubMed
50.
Shin HJ, Park HY, Jeong SJ, Park HW, Kim YK, Cho SH, Kim YY, Cho ML, Kim HY, Min KU, Lee CW: STAT4 expression in human T cells is regulated by DNA methylation but not by promoter polymorphism. J Immunol. 2005, 175: 7143-7150.CrossRefPubMed
51.
Hoffmann M, Pohlers D, Koczan D, Thiesen HJ, Wolfl S, Kinne RW: Robust computational reconstitution – a new method for the comparative analysis of gene expression in tissues and isolated cell fractions. BMC Bioinformatics. 2006, 7: 369-10.1186/1471-2105-7-369.PubMedCentralCrossRefPubMed
52.
Andreakos E, Sacre S, Foxwell BM, Feldmann M: The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis. Front Biosci. 2005, 10: 2478-2488. 10.2741/1712.CrossRefPubMed
53.
Zhang Z, Gorman C, Clark JM, Cope AP: Rheumatoid arthritis: a disease of chronic, low-amplitude signals transduced through T cell antigen receptors?. Wien Med Wochenschr. 2006, 156: 2-10. 10.1007/s10354-005-0246-5.CrossRefPubMed
54.
Takai T: Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol. 2005, 25: 1-18. 10.1007/s10875-005-0353-8.CrossRefPubMed
55.
Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T: Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford). 2006, 45: 669-675. 10.1093/rheumatology/kel065.CrossRef
56.
Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, Wagner U, Hantzschel H, Michel BA, Gay RE, Gay S, Kyburz D: Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol. 2004, 172: 1256-1265.CrossRefPubMed
57.
Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW: Constitutive upregulation of the TGF-b pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 2007, 9: R59-10.1186/ar2217.PubMedCentralCrossRefPubMed
58.
Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D: Angiogenesis in rheumatoid arthritis. Histol Histopathol. 2006, 21: 557-566.PubMed
59.
Kollias G, Douni E, Kassiotis G, Kontoyiannis D: The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis. 1999, 58 (Suppl 1): I32-I39.PubMedCentralCrossRefPubMed
60.
Rannou F, Francois M, Corvol MT, Berenbaum F: Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine. 2006, 73: 29-36. 10.1016/j.jbspin.2004.12.013.CrossRefPubMed
61.
Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L, Senices M, Wu PW, Sibley B, Leathurby Y, Brown TP, Nickerson-Nutter C, Keith JC, Collins M: Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 2007, 56: 1152-1163. 10.1002/art.22452.CrossRefPubMed
62.
63.
Haas CS, Amin MA, Ruth JH, Allen BL, Ahmed S, Pakozdi A, Woods JM, Shahrara S, Koch AE: In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum. 2007, 56: 2535-2548. 10.1002/art.22823.CrossRefPubMed
64.
Szekanecz Z, Koch AE: Update on synovitis. Curr Rheumatol Rep. 2001, 3: 53-63. 10.1007/s11926-001-0051-0.CrossRefPubMed
65.
Kawakami A, Urayama S, Yamasaki S, Hida A, Miyashita T, Kamachi M, Nakashima K, Tanaka F, Ida H, Kawabe Y, Aoyagi T, Furuichi I, Migita K, Origuchi T, Eguchi K: Anti-apoptogenic function of TGFbeta1 for human synovial cells: TGFbeta1 protects cultured synovial cells from mitochondrial perturbation induced by several apoptogenic stimuli. Ann Rheum Dis. 2004, 63: 95-97. 10.1136/ard.2003.014159.PubMedCentralCrossRefPubMed
66.
Bira Y, Tani K, Nishioka Y, Miyata J, Sato K, Hayashi A, Nakaya Y, Sone S: Transforming growth factor beta stimulates rheumatoid synovial fibroblasts via the type II receptor. Mod Rheumatol. 2005, 15: 108-113. 10.1007/s10165-004-0378-2.CrossRefPubMed
67.
Han Z, Boyle DL, Aupperle KR, Bennett B, Manning AM, Firestein GS: Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther. 1999, 291: 124-130.PubMed
68.
Ospelt C, Neidhart M, Gay RE, Gay S: Synovial activation in rheumatoid arthritis. Front Biosci. 2004, 9: 2323-2334. 10.2741/1399.CrossRefPubMed
69.
Forre O, Waalen K, Natvig JB, Kjeldsen-Kragh J: Evidence for activation of rheumatoid synovial T lymphocytes – development of rheumatoid T cell clones. Scand J Rheumatol Suppl. 1988, 76: 153-160. 10.3109/03009748809102965.CrossRefPubMed
70.
Vermeulen K, Berneman ZN, Van Bockstaele DR: Cell cycle and apoptosis. Cell Prolif. 2003, 36: 165-175. 10.1046/j.1365-2184.2003.00267.x.CrossRefPubMed
71.
Hayes AJ: Angioneogenesis in rheumatoid arthritis. Lancet. 1999, 354: 423-424. 10.1016/S0140-6736(05)75838-4.CrossRefPubMed
72.
Hirohata S, Sakakibara J: Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis. Lancet. 1999, 353: 1331-10.1016/S0140-6736(98)05912-1.CrossRefPubMed
73.
Gaur U, Aggarwal BB: Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003, 66: 1403-1408. 10.1016/S0006-2952(03)00490-8.CrossRefPubMed
74.
Malemud CJ: Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin Chim Acta. 2007, 375: 10-19. 10.1016/j.cca.2006.06.033.CrossRefPubMed
75.
Byrne AM, Bouchier-Hayes DJ, Harmey JH: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005, 9: 777-794. 10.1111/j.1582-4934.2005.tb00379.x.CrossRefPubMed
76.
Firestein GS, Alvaro-Gracia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol. 1990, 144: 3347-3353.PubMed
77.
Nakamura Y, Nawata M, Wakitani S: Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol. 2005, 167: 97-105.PubMedCentralCrossRefPubMed
78.
Middleton J, Americh L, Gayon R, Julien D, Aguilar L, Amalric F, Girard JP: Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky. Arthritis Res Ther. 2004, 6: 60-72. 10.1186/ar1156.PubMedCentralCrossRefPubMed
79.
Amu S, Stromberg K, Bokarewa M, Tarkowski A, Brisslert M: CD25-expressing B-lymphocytes in rheumatic diseases. Scand J Immunol. 2007, 65: 182-191. 10.1111/j.1365-3083.2006.01889.x.CrossRefPubMed
80.
Szodoray P, Alex P, Frank MB, Turner M, Turner S, Knowlton N, Cadwell C, Dozmorov I, Tang Y, Wilson PC, Jonsson R, Centola M: A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006, 45: 1466-1476. 10.1093/rheumatology/kel095.CrossRef
81.
Anolik JH, Ravikumar R, Barnard J, Owen T, Almudevar A, Milner EC, Miller CH, Dutcher PO, Hadley JA, Sanz I: Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol. 2008, 180: 688-692.CrossRefPubMed
82.
Dayer JM: Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?. J Rheumatol Suppl. 2002, 65: 10-15.PubMed
83.
Pardo A, Selman M: MMP-1: the elder of the family. Int J Biochem Cell Biol. 2005, 37: 283-288. 10.1016/j.biocel.2004.06.017.CrossRefPubMed
84.
Smolen J, Aletaha D: The burden of rheumatoid arthritis and access to treatment: a medical overview. Eur J Health Econ. 2008, 8 (Suppl 2): S39-S47. 10.1007/s10198-007-0087-9.CrossRefPubMed
85.
Hammaker DR, Boyle DL, Inoue T, Firestein GS: Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther. 2007, 9: R57-10.1186/ar2215.PubMedCentralCrossRefPubMed
86.
Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, Lin SJ, Rayan G, Koch AE: Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease. Clin Immunol Immunopathol. 1995, 76: 187-194. 10.1006/clin.1995.1114.CrossRefPubMed
Metadata
Title
Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane
Authors
René Huber
Christian Hummert
Ulrike Gausmann
Dirk Pohlers
Dirk Koczan
Reinhard Guthke
Raimund W Kinne
Publication date
01-08-2008
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2008
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2485

Other articles of this Issue 4/2008

Arthritis Research & Therapy 4/2008 Go to the issue

Research article

Disruption of the thrombospondin-2 gene alters the lamellar morphology but does not permit vascularization of the adult mouse lumbar disc

Research article

A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin®for treatment of osteoarthritis of the knee

Research article

Lack of association or interactions between the IL-4, IL-4Rα and IL-13 genes, and rheumatoid arthritis

Research article

Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis

Research article

A meta-analysis of the efficacy of fibromyalgia treatment according to level of care

Research article

Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits